The process of gauging and converting market opportunities and delivering on reimbursement expectations is a multi-step process that requires deep industry knowledge and insights. Guidehouse offers a multi-disciplinary, multi-functional view that helps our clients navigate the payer network and access critical data resources. Our dedicated team of pricing, market access, and policy experts can assist with the development, communication, and marketing of assets, and enable innovators to capture full value of their offerings.
Our market access services and solutions start with strategy development and extend through all phases of product development and commercialization, including:
- New product planning
- Pricing and contracting strategy
- HTA and evidence planning strategy
- Payer marketing
- Health economics and outcomes research
- Reimbursement policy
- Coding strategy
- Hub and patient services strategy
- Access launch excellence
Latest From Pricing Market Access & Reimbursement
September 29, 2021 PodcastInterested in Joining the Digital Therapeutics Revolution? Here’s How
June 21, 2021 InsightsThree Changes Coming to Drug PricingHere are three solid bets for pharma companies to plan for in the changing drug-pricing landscape.
April 30, 2021 InsightsEvolving a Market Access Strategy to Improve Patient AccessHow pharmaceutical companies should address payer needs during drug development and the role of market access through clinical development.
October 5, 2020 InsightsDigital Health Reimbursement: The Transforming LandscapeMed City News - Chance Scott, partner, talks about some of the challenges digital health innovators face, from reimbursement by private plans to the future of reimbursement for other telehealth tools and digital therapeutics.
February 27, 2020 InsightsHow to Successfully Mitigate Risk and Dissatisfaction in Patient Service ProgramsPublished in Pharmaceutical Executive
June 13, 2019 InsightsThe Biopharma Pipeline Is Strong, But Are New Innovations Reaching Patients?Eduardo Schur, Justin Zamirowski, Atin Patel, and Maya Desai in Bioprocess Online
March 2, 2017 InsightsUnlocking the Potential of Disease DataDetailed Classification Data Enables Targeted Drug Development